Holger Weis SEC EDGAR Filings (CIK 0001846984)

SEC EDGAR filings, ownership reports, and insider transactions for Holger Weis.

Business address
C/O Ziopharm Oncology, Inc., One First Avenue, Parris Bldg 34, Boston, MA, 02129
Top holdings (ownership)
JUNS
Get insider transactions for this reporting owner
Holger Weis has filed 11 SEC EDGAR filings since 22 Mar 2021

Latest Filings

Recent SEC filings for Holger Weis including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 20 Aug 2025 18 Aug 2025 001-33038
4 Open 4 document View SEC filing for 4 4 07 Jul 2025 02 Jul 2025 001-33038
4 Open 4 document View SEC filing for 4 4 15 Apr 2025 13 Apr 2025 001-33038
4 Open 4 document View SEC filing for 4 24 Jan 2025 22 Jan 2025 001-41265
3 Open 3 document View SEC filing for 3 08 Nov 2024 08 Nov 2024 001-41265
4 Open 4 document View SEC filing for 4 4 10 Jun 2024 06 Jun 2024 001-33038
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Jun 2023 06 Jun 2023 001-33038
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 24 Jun 2022 22 Jun 2022 001-33038
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Sep 2021 01 Sep 2021 001-33038
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 May 2021 04 Mar 2021 001-33038
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 22 Mar 2021 15 Dec 2020 001-33038

About this filer

Holger Weis files with the SEC under CIK 0001846984. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages